Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins

Metabolomics

Volumn 7, Issue 4, 2011, Pages 572-582

  Mallol, Roger ^a,c,d   Rodríguez, Miguel A ^a,c   Heras, Mercedes ^b,c   Vinaixa, Maria ^a,c   Cañellas, Nicolau ^a,c   Brezmes, Jesús ^a,c   Plana, Núria ^b,c   Masana, Lluís ^b,c   Correig, Xavier ^a,c  

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

1H NMR; Blood plasma; Diffusion coefficient; Dyslipidaemia; Lipoprotein; Surface fitting

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALGORITHM; ARTICLE; BLOOD ANALYSIS; CHYLOMICRONEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LORENTZIAN FUNCTION; MULTIVARIATE ANALYSIS OF VARIANCE; PARTICLE SIZE; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE FITTING ALGORITHM; TWO DIMENSIONAL EDITED PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 80054038159     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0273-8     Document Type: Article

References (47)

1. AlaKorpela, M. (1995) H-1 NMR spectroscopy of human blood plasma. Progress in Nuclear Magnetic Resonance Spectroscopy, 27, 475-554.
2. Ala-Korpela, M. (2008). Critical evaluation of H-1 NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clinical Chemistry and Laboratory Medicine, 46, 27-42.
3. AlaKorpela, M., Hiltunen, Y., & Bell, J. D. (1995). Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from H-1 NMR data of human plasma. NMR in Biomedicine, 8, 235-244.
4. Antalek, B. (2002). Using pulsed gradient spin echo NMR for chemical mixture analysis: How to obtain optimum results. Concepts in Magnetic Resonance, 14, 225-258.
5. Bachorik, P. S., & Ross, J. W. (1995). National-cholesterol-education-program recommendations for measurement of low-density-lipoprotein cholesterol-executive summary. Clinical Chemistry, 41, 1414-1420.
6. Bathen, T. F., Krane, J., Engan, T., Bjerve, K. S., & Axelson, D. (2000). Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR in Biomedicine, 13, 271-288.
7. Beckwith-Hall, B. M., Thompson, N. A., Nicholson, J. K., Lindon, J. C., & Holmes, E. (2003). A metabonomic investigation of hepatotoxicity using diffusion-edited H-1 NMR spectroscopy of blood serum. Analyst, 128, 814-818.
8. Cantor C. R., & Schimmel, P. R. (1980). Biophysical chemistry, part ii: Techniques for the study of biological structure and function. San Francisco: W. H. Freeman.
9. Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981). A density gradient ultra-centrifugal procedure for the isolation of the major lipoprotein classes from human-serum. Journal of Lipid Research, 22, 339-358.
10. Duell, P. B., Illingworth, D. R., & Connor, W. E. (2001). Endocrinology and metabolism (4th ed.). McGraw-Hill: New York.
11. Dyrby, M., Petersen, M., Whittaker, A. K., Lambert, L., Norgaard, L., Bro, R., et al. (2005). Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics. Analytica Chimica Acta, 531, 209-216.
12. Festa, A., Williams, K., Hanley, A. J. G., Otvos, J. D., Goff, D. C., Wagenknecht, L. E., et al. (2005). Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation, 111, 3465-3472.
13. Fossel, E. T., Carr, J. M., & McDonagh, J. (1986). Detection of malignant-tumors-water-suppressed proton nuclear-magnetic-resonance spectroscopy of plasma. New England Journal of Medicine, 315, 1369-1376.
14. Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998). Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1046-1053.
15. Friedewa, W. T, Fredrick, D. S., & Levy, R. I. (1972). Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
16. Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982). Separation and quantitation of subclasses of human-plasma high-density lipoproteins by a simple precipitation procedure. Journal of Lipid Research, 23, 1206-1223.
17. Gofman, J. W., Lindgren, F. T., & Elliott, H. (1949). Ultracentrifugal studies of lipoproteins of human serum. Journal of Biological Chemistry, 179, 973-979.
18. Jerschow, A., & Muller, N. (1997). Suppression of convection artifacts in stimulated-echo diffusion experiments. Double-stimulated-echo experiments. Journal of Magnetic Resonance, 125, 372-375.
19. Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006). Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clinics in Laboratory Medicine, 26, 847-870.
20. Jialal, I., Hirany, S. V., Devaraj, S., & Sherwood, T. A. (1995). Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation). American Journal of Clinical Pathology, 104, 76-81.
21. Johnson, C. S. (1999). Diffusion ordered nuclear magnetic resonance spectroscopy: Principles and applications. Progress in Nuclear Magnetic Resonance Spectroscopy, 34, 203-256.
22. Kesmarky, G., Kenyeres, P., Rabai, M., & Toth, K. (2008). Plasma viscosity: A forgotten variable. Clin. Hemorheol. Microcirc., 39, 243-246.
23. Kremer, W., Kalbitzer, H. R., & Huber, F. (2008). US Patent Application 2008/0038829 A1.
24. Kumpula, L. S., Makela, S. M., Makinen, V. P., Karjalainen, A., Liinamaa, J. M., Kaski, K., et al. (2010). Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps. Journal of Lipid Research, 51, 431-439.
25. Lamarche, B., & Lewis, G. F. (1998). Atherosclerosis prevention for the next decade: Risk assessment beyond low density lipoprotein cholesterol. Canadian Journal of Cardiology, 14, 841-851.
26. Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despres, J. P. (1997). Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men-prospective results from the Quebec cardiovascular study. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1098-1105.
27. Liu, M. L., Tang, H. R., Nicholson, J. K., & Lindon, J. C. (2002). Use of H-1 NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma. Magnetic Resonance in Chemistry, 40, S83-S88.
28. Lounila, J., Alakorpela, M., Jokisaari, J., Savolainen, M. J., & Kesaniemi, Y. A. (1994). Effects of orientational order and particle-size on the NMR line positions of lipoproteins. Physical Review Letters, 72, 4049-4052.
29. Nicholson, J. K., Foxall, P. J. D., Spraul, M., Farrant, R. D., & Lindon, J. C. (1995). 750-Mhz H-1 and H-1-C-13 NMR-spectroscopy of human blood-plasma. Analytical Chemistry, 67, 793-811.
30. Noble, R. P. (1968). Electrophoretic separation of plasma lipoproteins in agarose gel. Journal of Lipid Research, 9, 693-700.
31. Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992). Development of a proton nuclear-magnetic-resonance spectroscopic method for determining plasma-lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clinical Chemistry, 38, 1632-1638.
32. Otvos, J. D., Jeyarajah, E. J., Hayes, L. W., Freedman, D. S., Janjan, N. A., & Anderson, T. (1991). Relationships between the proton nuclear-magnetic-resonance properties of plasma-lipoproteins and cancer. Clinical Chemistry, 37, 369-376.
33. Petersen, M., Dyrby, M., Toubro, S., Engelsen, S. B., Norgaard, L., Pedersen, H. T., et al. (2005). Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models. Clinical Chemistry, 51, 1457-1461.
34. Roheim, P. S., & Asztalos, B. F. (1995). Clinical-significance of lipoprotein size and risk for coronary atherosclerosis. Clinical Chemistry, 41, 147-152.
35. Rosenson, R. S., Shott, S., & Tangney, C. C. (2002). Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: Triglycerides and blood viscosity. Atherosclerosis, 161, 433-439.
36. Savorani, F., Kristensen, M., Larsen, F. H., Astrup, A., & Engelsen, S. B. (2010). High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics. Nutrition & Metabolism, 7, 8.
37. Schaefer, E. J., Anderson, D. W., Brewer, H. B., Levy, R. I., Danner, R. N., & Blackwelder, W. C. (1978). Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet, 2, 391-393.
38. Schectman, G., Patsches, M., & Sasse, E. A. (1996). Variability in cholesterol measurements: Comparison of calculated and direct LDL cholesterol determinations. Clinical Chemistry, 42, 732-737.
39. Schumaker, V. N., & Puppione, D. L. (1986). Sequential flotation ultracentrifugation. Methods in Enzymology, 128, 155-170.
40. Seplowitz, A. H., Chien, S., & Smith, F. R. (1981). Effects of lipoproteins on plasma viscosity. Atherosclerosis, 38, 89-95.
41. Stein, E. A., & Myers, G. L. (1995). National-cholesterol-education-program recommendations for triglyceride measurement-executive summary. Clinical Chemistry, 41, 1421-1426.
42. Suna, T., Salminen, A., Soininen, P., Laatikainen, R., Ingman, P., Makela, S., et al. (2007). H-1 NMR metabonomics of plasma lipoprotein subclasses: Elucidation of metabolic clustering by self-organising maps. NMR in Biomedicine, 20, 658-672.
43. Thompson, G. R. (1998). Angiographic evidence for the role of triglyceride-rich lipoproteins in progression of coronary artery disease. European Heart Journal, 19, H31-H36.
44. Tyrrell, H. J. V., & Harris, K. R. (1984). Diffusion in liquids: A theoretical and experimental study. London: Butterworths.
45. Vehtari, A., Makinen, V. P., Soininen, P., Ingman, P., Makela, S. M., Savolainen, M. J., et al. (2007). A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in H-1 NMR metabonomic data. Bmc Bioinformatics, 8(suppl 2).
46. Warnick, G. R., & Wood, P. D. (1995). National-cholesterol-education-program recommendations for measurement of high-density-lipoprotein cholesterol-executive summary. Clinical Chemistry, 41, 1427-1433.
47. Wu, P. S. C., & Otting, G. (2005). Rapid pulse length determination in high-resolution NMR. Journal of Magnetic Resonance, 176, 115-119.